EMEA-001539-PIP01-13-M05

Key facts

Invented name
Lokelma
Active substance
sodium zirconium cyclosilicate
Therapeutic area
Endocrinology-Gynaecology-Fertility-Metabolism
Decision number
P/0477/2021
PIP number
EMEA-001539-PIP01-13-M05
Pharmaceutical form(s)
Powder for oral suspension
Condition(s) / indication(s)
Treatment of hyperkalaemia
Route(s) of administration
Oral use
Contact for public enquiries
AstraZeneca AB

E-mail: paediatrics@astrazeneca.com
Tel. +46(8)55324400

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating